<DOC>
	<DOCNO>NCT01055041</DOCNO>
	<brief_summary>The purpose study know effect another controller medication add inhaled corticosteroid long act Î²2 agonist clinical symptom , lung function compliance patient moderate severe persistent bronchial asthma .</brief_summary>
	<brief_title>Controller Medications Management Bronchial Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Doxofylline</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>age 15 65 year either sex clinically diagnose Bronchial asthma poor asthma control define ACQ score ( asthma control questionnaire ) 1.5 great FEV1 ( Forced Expiratory Volume 1 second ) value 50 % predict improvement FEV1 great 15 % bronchodilator inhalation major illness system respiratory major respiratory illness asthma take long act anti histaminic within precede week enrollment Smokers Pregnant lactate woman history hypersensitivity drug</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>